CTRI/2021/10/037469CompletedPhase 2
An Open Label In-Vitro, In-Vivo Study To Evaluate The Anti-Inflammatory Action Of Gugguluthikthakam Kashaya And Simhanada Guggulu Followed By Clinical Study In Rheumatoid Arthritis
Mandsaur Institute Of Ayurveda Education And Research0 sites60 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Eligible subjects either male or female with diagnosed RA according to the revised 2010 American College of Rheumatology (ACR) criteria and Disease Activity Score (DAS).
Exclusion Criteria
- •Deformities and malformations of Musculoskeletal system, Pregnancy and lactation and RA Secondary to any disease will be excluded.
Investigators
Similar Trials
Not yet recruiting
Phase 3
Treatment of acidity with Unani medicine Qurs-e-AtashCTRI/2021/06/033950Central Council for Research in Unani Medicine CCRUM New Delhi
Not yet recruiting
Phase 3
Treatment of Rheumatoid Arthritis(pain and swelling in joints) with Unani medicines Majoon-e-Azaraqi and Roghan-e-SurkhCTRI/2021/05/033636Central Council for Research in Unani Medicine CCRUM New Delhi
Not yet recruiting
Phase 3
Treatment of Irq-Un-Nisa (Sciatica) with Unani medicine Habb-e-Irq-un-NisaCTRI/2022/01/039133Central Council for Research in Unani Medicine CCRUM New Delhi
Not yet recruiting
Phase 3
Treatment of Nisyan (Amnesia) with Unani medicine Majun BoolusCTRI/2021/07/034593Central Council for Research in Unani Medicine CCRUM New Delhi
Not yet recruiting
Phase 3
Treatment of difficulty or trouble in breathing with Unani medicine Laooq-e-HulbaCTRI/2023/04/051554Central Council for Research in Unani Medicine CCRUM New Delhi